Acrivon Therapeutics Inc. – Filings and Transcripts

NASDAQ: ACRV
Share price (5/22/26): $1.75
Market cap (5/22/26): $74.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Shelf registration

Registration of securities for employees

Ownership Filter

RA Capital Healthcare Fund LP, Ra Capital Management, L.P., Kolchinsky Peter, Shah Rajeev M., RA Capital Nexus Fund II, L.P.

Tomsicek Michael John

Palani Santhosh

Magovcevic-Liebisch Ivana

News Filter

Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts

Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Termination of Material Definitive Agreement

Investor Presentation

Investor Presentation

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Correspondence with the SEC